Pancreatic Cancer, Adult
22
10
11
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
4.5%
1 terminated out of 22 trials
75.0%
-11.5% vs benchmark
5%
1 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (22)
Pancreatic Cancer Screening for At-risk Individuals
Association Between Chronic Psychological Stress and Disease Course Outcomes in Pancreatic Cancer
Surveillance of Pancreatic Health After Diabetes Diagnosis
Prehab for Pancreatic Cancer Surgery
Surufatinib Plus Gemcitabine and Nab-paclitaxel vs. Gemcitabine Plus Nab-paclitaxel in Neoadjuvant Therapy for High - Risk Resectable or Borderline Resectable Pancreatic Cancer
Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer
The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cell Transcriptomic Profiling
Pancreatic Cancer Detection Consortium
Nimotuzumab Combined With Nab-paclitaxel/Gemcitabine in the Perioperative Treatment of High-risk Resectable/Borderline Resectable Pancreatic Cancer
Adebrelimab and Chidamide for Pancreatic Cancer
Trial to Evaluate Safety and Tolerability of GP-2250 in Combination With Gemcitabine
Effects of Peptamen 1.6 in Malnourished Patients (or at Risk) With Pancreatic Neoplasia Undergoing Cephalic Pancreaticoduodenectomy (CPD): A Mechanistic Study
QUILT-3.010: A Study of Gemcitabine and Nab-paclitaxel With or Without NPC-1C to Treat Patients With Pancreatic Cancer
Raman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early Diagnosis
AG Plus Nimotuzumab Sequential Irreversible Electroporation Ablation for Locally Advanced Pancreatic Cancer
Gut Microbiota Analysis in Patients Undergoing Duodencephalopancreasectomy for Pancreatic Cancer
PREVENPANC Project: a Spanish Multicenter Study for Pancreatic Cancer Prevention
Neutrophil-to-lymphocyte Ratio and CA 19.9 as Predictors of Perineural Invasion in Pancreatic Cancer
Tracheal Colonization and Outcome After Major Abdominal Cancer Surgery
Usefulness of the Artery First Approach in Pancreatic Cancer Surgery